Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Polman

Showing results (191-200 of 290) with videos related to

Pageof 29
Sort By:
Journal of Neuroimmunology|November 26, 2002
Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosisM J Eikelenboom, J Killestein, T Izeboud, et al.
Journal of Neurology|July 1, 1993
Fatigue, sleep disturbances and circadian rhythm in multiple sclerosisM J Taphoorn, E van Someren, F J Snoek, et al.
Neurology|January 28, 2004
Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examinationJ C J Bot, F Barkhof, C H Polman, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 24, 1999
Factor structure of the Disability and Impact Profile in patients with multiple sclerosisL Cohen, F Pouwer, L E Pfennings, et al.
Journal of Neuroimmunology|May 5, 1999
Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patientsM H Rep, H M Schrijver, T van Lopik, et al.
Annals of Neurology|August 17, 2001
Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosisT van Veen, J B Crusius, H M Schrijver, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal studyA C J W Janssens, D Buljevac, P A van Doorn, et al.
European Journal of Neurology|June 10, 2010
EFNS guidelines on diagnosis and management of neuromyelitis opticaJ Sellner, M Boggild, M Clanet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 30, 2014
A dam for retrograde axonal degeneration in multiple sclerosis?L J Balk, J W R Twisk, M D Steenwijk, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 3, 2007
Motor evoked potential: a reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRIN F Kalkers, R L M Strijers, M M S Jasperse, et al.
Pageof 29

Showing results (191-200 of 290) with videos related to

Sort By:
Pageof 29
Journal of Neuroimmunology|November 26, 2002
Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosisM J Eikelenboom, J Killestein, T Izeboud, et al.
Journal of Neurology|July 1, 1993
Fatigue, sleep disturbances and circadian rhythm in multiple sclerosisM J Taphoorn, E van Someren, F J Snoek, et al.
Neurology|January 28, 2004
Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examinationJ C J Bot, F Barkhof, C H Polman, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 24, 1999
Factor structure of the Disability and Impact Profile in patients with multiple sclerosisL Cohen, F Pouwer, L E Pfennings, et al.
Journal of Neuroimmunology|May 5, 1999
Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patientsM H Rep, H M Schrijver, T van Lopik, et al.
Annals of Neurology|August 17, 2001
Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosisT van Veen, J B Crusius, H M Schrijver, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal studyA C J W Janssens, D Buljevac, P A van Doorn, et al.
European Journal of Neurology|June 10, 2010
EFNS guidelines on diagnosis and management of neuromyelitis opticaJ Sellner, M Boggild, M Clanet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 30, 2014
A dam for retrograde axonal degeneration in multiple sclerosis?L J Balk, J W R Twisk, M D Steenwijk, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 3, 2007
Motor evoked potential: a reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRIN F Kalkers, R L M Strijers, M M S Jasperse, et al.
Pageof 29